both contain a carboxy-terminal hydrophobic region, which presumably serves as a membrane anchor. When they are expressed in animal cell cultures, these glycoproteins, in both mature complexes and misfolded aggregates, are retained in the endoplasmic reticulum. The effect of carboxyterminal deletions on HCV glycoprotein secretion and folding was examined in this study. Sindbis and/or vaccinia virus recombinants expressing truncated forms of these glycoproteins ending at amino acids 311, 330, 354 and 360 (truncated E1), and 661, 688, 704 and 715 (truncated E2) were constructed. When expressed using Sindbis virus vectors, only truncated forms of E1 and E2 ending at amino acids 311 (E1 t311 ) and 661 (E2 t661 ), respectively, were efficiently secreted. Analysis of
Introduction
Hepatitis C virus (HCV), the major causative agent of non-A, non-B hepatitis (Choo et al., 1989 ; Kuo et al., 1989) , is an enveloped virus with a positive-stranded RNA genome of approximately 9500 nucleotides (Choo et al., 1989 . HCV has been classified in the family Flaviviridae (Francki et al., 1991) . Its genome contains highly conserved 5h and 3h noncoding regions (Kolykhalov et al., 1996 ; Tanaka et al., 1996) . The 5h noncoding region is followed by a long open reading frame encoding a 3010-3033 amino acid polyprotein (reviewed by Matsuura & Miyamura, 1993) . This polyprotein is processed by a combination of host and viral proteinases to produce the putative viral structural and nonstructural proteins (for a review see Rice, 1996) .
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Fax j33 3 20 87 11 11. e-mail jdubuis!infobiogen.fr secretion of truncated forms of E2 glycoprotein expressed by vaccinia viruses indicated that significant secretion was still observed for a protein as large as E2 t715 . However, only secreted E2 t661 appeared to be properly folded. Secreted HCV glycoprotein complexes were also detected in the supernatant of cell culture when E1 t311 and E2 t661 were coexpressed. Nevertheless, these secreted complexes, as well as E1 t311 expressed alone, were misfolded. The effect of coexpression of E1 and E2 glycoproteins on each other's folding was evaluated with the help of a conformation-sensitive monoclonal antibody (for E2) or by analysing intramolecular disulfide bond formation (for E1). Our data indicate that the folding of E2 is independent of E1, but that E2 is required for the proper folding of E1.
The HCV genome encodes two membrane-associated envelope glycoproteins (E1 and E2), which are released from the polyprotein by host signal peptidase cleavages. E1 and E2 glycoproteins interact to form a complex which has been proposed as a functional subunit of HCV virions (Dubuisson et al., 1994 ; Grakoui et al., 1993 ; Lanford et al., 1993 ; Ralston et al., 1993) . Characterization of HCV glycoprotein complex formation, using the vaccinia\T7 or Sindbis virus expression systems, indicates that the majority of HCV glycoproteins are misfolded (Deleersnyder et al., 1997 ; Dubuisson et al., 1994) . Recently, we have produced a monoclonal antibody (MAb) that recognizes a form of E2 which is likely to be properly folded and may represent a precursor to the mature HCV glycoprotein in infectious HCV particles. This MAb shows delayed reactivity with E2 and it selectively recognizes E2 present in noncovalently associated E1E2 heterodimers, but not misfolded disulfide-linked aggregates (Deleersnyder et al., 1997) . Such E1E2 heterodimers form slowly and even mature heterodimers do not leave the endoplasmic reticulum (ER), suggesting that E1 and\or E2 contains a signal for retention of the heterodimer in this compartment (Deleersnyder et al., 1997) .
The HCV glycoproteins contain hydrophobic domains in their carboxy-terminal regions, which presumably act as membrane anchors, giving the proteins a type I membrane topology (Rice, 1996) . The E2 glycoprotein extends to residue 746 (position on the polyprotein) and deletion of at least 31 carboxy-terminal amino acids can lead to its secretion (Selby et al., 1994) . This is in accordance with other data proposing that the hydrophobic anchor domain begins at amino acid 718 (Mizushima et al., 1994) . The situation appears to be more confusing for E1, since a truncated form ending at amino acid 340 was secreted only if it contained an internal deletion between amino acids 262 and 290, suggesting that a second membrane anchor domain might exist (Matsuura et al., 1994) . This truncated form of E1 and a truncated E2 glycoprotein ending at amino acid 668 were shown to interact and yield a secreted complex upon coexpression of these proteins (Matsuura et al., 1994) . In this report, Sindbis and\or vaccinia virus recombinants expressing truncated HCV glycoproteins were constructed. Significant differences in the levels of secretion of truncated E2 were observed, depending on the vector. However, in both expression systems, only a secreted form of E2 glycoprotein ending at amino acid 661 appeared to be properly folded. For E1, a truncated form ending at amino acid 311 was secreted in both expression systems, but it was misfolded. In addition, our data indicate that E2 is required for the proper folding of E1.
Methods
Cell culture. BHK-21, HepG2, Vero, Hela, CV-1 and 143B tk − (thymidine kinase-deficient) cell lines were obtained from the American Type Culture Collection (ATCC), Rockville, Md., USA. BHK-21 cell monolayers were grown in alpha minimum essential medium supplemented with 10 % foetal bovine serum. HepG2, Vero, Hela, CV-1 and 143B tk − cell monolayers were grown in Dulbecco's modified essential medium supplemented with 10 % foetal bovine serum.
Plasmid constructs. Sindbis virus-HCV recombinants were constructed by using pSINrep5 (Bredenbeek et al., 1993) and standard methodology (Sambrook et al., 1989) . Plasmid pSINrep\HCV1-1207 has been previously described (Dubuisson et al., 1994) . For other constructs, selected regions of the HCV coding region (as indicated by the HCV polyprotein residue numbers) were amplified by PCR to position a 5h MluI site, an AUG start codon and a TAA stop codon followed by a 3h ApaI site. PCR products were digested with MluI and ApaI and cloned into pSINrep5 (Bredenbeek et al., 1993) . The sequences of these clones were confirmed by DNA sequencing. A double subgenomic Sindbis virus recombinant (pSINrep\HCV171-311\HCV370-661) expressing truncated E1 and E2 (ending at amino acids 311 and 661, respectively) was constructed as described by Hahn et al. (1992) . Briefly, the E2-coding sequence from pSINrep\HCV370-661 was subcloned into the phagemid shuttle vector pH3h2J1 and then an ApaI fragment which contained a second copy of the subgenomic promoter driving expression of E2 t''" was subcloned into the ApaI site of pSINrep\HCV171-311.
Selected regions encoding HCV glycoprotein E1 or E2 were PCRamplified and inserted into NcoI-StuI-digested pTM1 (Moss et al., 1990) for truncated E1, BssHII-StuI-digested pTM1\E2-p7 (Fournillier-Jacob et al., 1996) or BamHI-StuI-digested pTM1\HCV170-809 (A. FournillierJacob & C. Wychowski, unpublished data) to generate plasmid constructs pTM1- Generation and growth of viruses. Stocks of Sindbis virus recombinants were generated as described by Bredenbeek et al. (1993) , using DH-(26S)5hSIN helper RNA. To estimate the titres of the stocks of Sindbis virus-HCV recombinants, serial dilutions of each stock were adsorbed on BHK-21 cells in 96-well plates. After 7-8 h incubation at 37 mC, plates were fixed for 15 min at 4 mC with cold isopropanol, and the number of particles (infectious units) was determined as previously described (Dubuisson et al., 1994) .
Vaccinia virus recombinants were generated by homologous recombination essentially as described by Kieny et al. (1984) and plaquepurified twice on 143B tk − cells under bromodeoxyuridine selection (50 µg\ml). Stocks of vTF7-3 (a vaccinia virus recombinant expressing the T7 DNA-dependent RNA polymerase) (Fuerst et al., 1986) , the wildtype vaccinia virus Copenhagen strain and its thermosensitive ts7 derivative (Drillien et al., 1982) and vaccinia virus-HCV recombinants were grown and titrated on CV-1 monolayers.
Antibodies. Anti-E1 (A4) and anti-E2 (A11 and H2) MAbs have been previously described (Deleersnyder et al., 1997 ; Dubuisson et al., 1994) .
Metabolic labelling and immunoprecipitation. Cells were infected and metabolically labelled with Tran$&S-label (ICN) as previously described (Dubuisson et al., 1994 ; Dubuisson & Rice, 1996) . Labelled infected cells were then lysed with 0n5 % NP-40 in 10 mM Tris-HCl pH 7n5, 150 mM NaCl and 2 mM EDTA. For experiments in which disulfide bond formation was determined, 20 mM iodoacetamide was included in the lysis buffer. Immunoprecipitations were carried out as previously described (Dubuisson & Rice, 1996) .
Endoglycosidase digestions. Immunoprecipitated proteins were eluted from protein A-Sepharose in 30 µl 0n5 % SDS by boiling for 10 min in the presence (reducing conditions) or absence (nonreducing conditions) of 1 % 2-mercaptoethanol. The protein samples were then divided into two equal portions for digestion with endo-β-Nacetylglucosaminidase H (Endo H ; New England Biolabs) or an undigested control. Similar digestions were performed with PNGase F (New England Biolabs). Digestions were carried out for 1 h at 37 mC in the buffer provided by the manufacturer. Digested samples were mixed with an equal volume of 2i Laemmli sample buffer and analysed by SDS-PAGE.
Sedimentation through sucrose gradients. Supernatant from labelled infected cells was layered on a 10 ml gradient of 5-20 % sucrose in TBS. After centrifugation at 4 mC for 24 h at 36 000 r.p.m. in a Beckman SW41 rotor, 11 fractions were collected from the bottom of the gradient and analysed by immunoprecipitation. Molecular mass markers (Combithek, calibration protein I ; Boehringer Mannheim) were sedimented in a parallel sucrose gradient.
Results

Secretion of truncated HCV glycoproteins
In order to produce secreted forms of HCV glycoproteins which would be useful for further biochemical and biological CDAA Truncated HCV glycoproteins Truncated HCV glycoproteins characterization, carboxy-terminal deletion mutants of E1 and E2 ( Fig. 1) were constructed. These truncated glycoproteins were expressed using Sindbis and vaccinia virus expression systems. Intracellular and secreted HCV glycoproteins were identified by immunoprecipitation analysis with conformationinsensitive MAbs (Fig. 2) . The migration patterns of truncated E2 glycoproteins were in accordance with the size of their deletion (Fig. 2 B) . However, this was not the case for E1, for which there was a slight reduction in mobility for some truncated forms (Fig. 2 A) . This has been reported previously and might be due to abnormal electrophoretic mobility (Fournillier-Jacob et al., 1996) . In addition, immunoprecipitation of intracellular truncated HCV E1 glycoproteins showed multiple bands (Fig. 2 A) , which were resolved as a single band after Endo H or PNGase F treatment (data not shown), indicating that this pattern is due to variable glycosylation as previously shown (Dubuisson et al., 1994 ; Lanford et al., 1993) .
While the Sindbis virus system is useful for expressing proteins in, for example, BHK-21 cells, some cell lines (e.g. HepG2) are poorly infected by Sindbis virus ; in contrast, vaccinia virus allows expression in most cell types. With the Sindbis virus expression system, significant secretion was only observed for truncated forms of E1 and E2 ending at amino acids 311 (E1 t$"" ; SINrep\HCV171-311) and 661 (E2 t''" ; SINrep\HCV370-661), respectively ( Fig. 2 A, B) . When the same regions of E2 were expressed by vaccinia virus, E2 t''" was efficiently secreted, but significant secretion was also observed for truncated E2 glycoproteins ending at amino acids 688, 704 and 715 expressed in HepG2 cells (Fig. 2 C) or in BHK-21 cells (data not shown). In addition, coexpression of E1 with these truncated forms of E2 had no influence on the level were labelled under the same conditions. HCV proteins present in the cell lysates (left panels) or the supernatant (right panels) of infected cells were immunoprecipitated with anti-E1 (A4) or anti-E2 (A11) MAbs. After immunoprecipitation, samples were separated by SDS-PAGE. HCV-specific proteins are indicated on the left. Sizes (in kDa) of protein molecular mass markers are indicated on the right. of secretion (Fig. 2 C and data not shown) . This indicates that the expression system utilized can influence the level of secretion of these E2 truncations.
The molecular masses of the truncated E1 and E2 glycoproteins were higher for the secreted forms than for the intracellular proteins (Figs 2 and 3) , suggesting that the extracellular glycoproteins acquired additional modification during secretion. This appears to be the acquisition of complex glycans, as shown by their resistance to Endo H digestion and their sensitivity to PNGase F digestion (Fig. 3) . Similar results were observed for other secreted forms of E2 expressed by vaccinia virus (data not shown). These results also demonstrate that the proteins were actually secreted and not simply released into the supernatant after cell death.
Characterization of secreted forms of truncated HCV glycoproteins
A large portion of HCV glycoproteins expressed in tissue culture form aggregates, stabilized by disulfide bonds CDAB J.-P. Michalak and others J.-P. Michalak and others Dubuisson et al., 1994 ; Dubuisson & Rice, 1996) , which have been proposed to be dead-end products (Deleersnyder et al., 1997) . Since similar aggregates can also be observed when E1 or E2 is expressed alone (data not shown), the secreted forms of truncated HCV glycoproteins precipitated by a conformation-insensitive MAb were also analysed by SDS-PAGE under nonreducing conditions to determine their capacity to form aggregates (Fig. 4) . Under such conditions some secreted forms of truncated E2 (E2 t''" , E2 t')) or E2 t("& ) showed bands of high molecular mass at the top of the gel which were not detected under reducing conditions. In addition, the monomeric form of E2 t("& was not detected when analysed under nonreducing conditions, suggesting that the majority of secreted E2 t("& formed aggregates whereas a large portion of E2 t''" was monomeric (Fig. 4 A) . To evaluate the acquisition of intramolecular disulfide bonds by the secreted E2 t''" , the protein was deglycosylated by PNGase F digestion before its separation by SDS-PAGE under reducing or nonreducing conditions as previously described (Dubuisson & Rice, 1996) . The nonreduced E2 t''" expressed using Sindbis (Fig. 4 B) or vaccinia virus vectors (data not shown) migrated faster than its reduced form, suggesting that E2 t''" had acquired a compactly folded conformation. For E1 t$"" , a faint band migrating faster in nonreducing conditions, corresponding to its oxidized form, and a ladder of presumably disulfidelinked aggregates were detected (Fig. 4 B) . This demonstrates considerable heterogeneity in the secreted form of E1.
Recently, we have isolated and characterized a MAb (H2) which recognizes properly folded E2 and precipitates native glycoprotein complexes but not aggregated forms (Deleersnyder et al., 1997) . Since this MAb recognizes properly folded E2 glycoprotein, it has been used in this work to characterize the folding state of secreted forms of truncated E2 glycoproteins. As shown in Fig. 4 (A) , secreted E2 t''" was well recognized by MAb H2, whereas the other secreted forms were poorly (E2 t')) ) or not (E2 t("& ) recognized. These results suggest that a truncation of as much as 85 amino acids is necessary for secretion of properly folded truncated E2. Together these results suggest that E2 t''" is probably the only truncated HCV glycoprotein produced in this work which could be useful for further biochemical or biological studies.
We have previously shown that HCV glycoproteins E1 and E2 interact to form a heterodimer which is retained in the ER (Deleersnyder et al., 1997 ; Dubuisson et al., 1994) . In order to determine whether the expression of a large domain of E2 (E2 t''" ) in the absence of E1 would induce self-oligomerization, CDAC Truncated HCV glycoproteins Truncated HCV glycoproteins Fig. 5 . Kinetics of folding of E2 t661 and full-length E2 expressed in the presence or absence of E1. HepG2 cells coinfected with vTF7-3 and vHCV recombinants expressing E2 or a truncated form (vHCV170-809, vHCV371-809 or vHCV371-661) were pulse-labelled for 5 min and chased for the indicated times (min). The E2 glycoprotein was immunoprecipitated with MAb H2. Immunoprecipitates were analysed under reducing conditions by SDS-PAGE (10 % acrylamide gel) and quantification was performed with a PhosphorImager. For E2 t661 , both intracellular (i.c.) and extracellular (e.c.) immunoprecipitates were measured. secreted E2 t''" was analysed by sedimentation through a 5-20 % sucrose gradient. By immunoprecipitation with MAb H2, E2 t''" cosedimented with the molecular mass marker of 68 kDa, suggesting that the properly folded form of secreted E2 t''" behaves as a monomer (data not shown).
Folding of E1 is dependent on the coexpression of E2
Since misfolding was observed for some truncated forms of the HCV glycoproteins, we suspected that coexpression of these proteins might be necessary for their correct folding. Folding of E2 was monitored by following the kinetics of detection by the conformation-sensitive MAb H2 (Deleersnyder et al., 1997) . As shown in Fig. 5 , the kinetics of E2 folding in the presence or absence of E1 were very similar, suggesting that the presence of E1 is not necessary for E2 folding. However, the folding kinetics of E2 t''" were faster and, because it was secreted, intracellular E2 t''" precipitated by MAb H2 decreased after a 2 h chase.
Since no MAb which recognizes properly folded E1 glycoprotein is currently available, we monitored disulfide Fig. 6 . Oxidation of the E1 glycoprotein expressed in the presence or absence of E2. BHK-21 cells coinfected with vTF7-3 and vHCV1-746 or vHCV1-383 were pulse-labelled for 5 min and chased for the indicated times (min). The E1 glycoprotein was immunoprecipitated with anti-E1 MAb (A4). Immunoprecipitates were analysed under nonreducing condition by SDS-PAGE (10 % acrylamide gel). E1red, reduced E1 ; E1ox, oxidized E1. bond formation by SDS-PAGE under nonreducing conditions as previously described (Dubuisson & Rice, 1996) . An oxidized form of E1, which appeared slowly, was clearly detected when E2 was coexpressed with E1 ( Fig. 6 ) as previously observed (Dubuisson & Rice, 1996) . In the absence of E2, no oxidized form of E1 (Fig. 6 ) or E1 t$"" (data not shown) was detected. These results suggest that E2 expressed in cis affects the folding of E1.
Formation of complexes involving truncated HCV glycoproteins
It has recently been shown that some truncated forms of E1 and E2 proteins secreted into the supernatant of the cell culture can be detected as complexes (Matsuura et al., 1994) . However, other data suggest that in the absence of the carboxy-terminal part of E2 (presumably its transmembrane domain), no E1E2 complex can be formed (Selby et al., 1994) . These data, which seem contradictory, were reanalysed with the tools we have recently developed to measure HCV glycoprotein folding and CDAD J.-P. Michalak and others J.-P. Michalak and others Fig. 8 . Absence of coprecipitation of intracellular truncated forms of E2 with full-length E1. HepG2 cells coinfected with vTF7-3 and vHCV recombinants expressing E1 plus E2 deleted at its carboxy-terminus (vHCV170-661, vHCV170-688, vHCV170-704 or vHCV170-715), or E1 and E2 (vHCV170-809) were labelled from 4-9 h p.i. HCV glycoproteins were immunoprecipitated with anti-E1 MAb A4 (A) or anti-E2 MAb A11 (B) and separated by SDS-PAGE (10 % acrylamide gel) under reducing conditions. HCV-specific proteins are indicated on the left. Sizes (in kDa) of protein molecular mass markers are indicated on the right.
assembly (Deleersnyder et al., 1997 ; Dubuisson & Rice, 1996) . To evaluate the secretion of complexes formed between truncated forms of E1 and E2, immunoprecipitations were performed from the supernatant of BHK-21 cells coinfected with vTF7-3 and vHCV170-311 and vHCV371-661. As shown in Fig. 7 , E2 t''" coprecipitated with E1 t$"" when a conformation-insensitive MAb (A4) was used, confirming that soluble E1E2 complexes can be formed. However, no coprecipitation of E1 t$"" was detected when our conformationsensitive MAb (H2) was used. In addition, under nonreducing conditions, the majority of HCV glycoproteins precipitated by MAb A4 were detected in the upper part of the gel, suggesting that they form aggregates. Similar results were observed when these proteins were expressed by Sindbis virus vectors (data not shown). These observations suggest that the majority of secreted HCV glycoprotein complexes are not properly folded. To evaluate the role of the carboxy-terminal part of E2 in the assembly of E1E2 complexes, the same carboxy-terminal deletions of E2 as described above were expressed in the context of a polyprotein. No association between E1 and E2 was detected by immunoprecipitation with anti-E1 or anti-E2 MAbs when deletions were introduced in the carboxy terminus of E2 (Fig. 8) . These results confirm the observations of Selby et al. (1994) and indicate that the carboxy-terminal domain of E2 (presumably its transmembrane domain) may be important for heterodimer formation.
When full-length E2 was coexpressed with a truncated form of E1, intracellular E1E2 complexes were detected by immunoprecipitation with a conformation-insensitive MAb (A4) (data not shown). However, no coprecipitation of E1 t$"" was detected when our conformation-sensitive anti-E2 MAb (H2) was used. In addition, under nonreducing conditions, the majority of HCV glycoproteins precipitated by MAb A4 were detected in the upper part of the gel (data not shown), suggesting that they form aggregates.
Discussion
Secreted forms of viral glycoproteins can be valuable for elucidating their biological functions (Harrison et al., 1996) . In the case of HCV, secreted glycoprotein ectodomains should be useful for characterizing modifications which occur during their transit through the secretory pathway. Properly folded forms can be used in biochemical studies, such as defining the nature of E2 intramolecular disulfide bonds. Secreted HCV glycoproteins can also be used to study their interaction with the cell surface (Rosa et al., 1996) , or for diagnostic purposes (Lesniewski et al., 1995) . In this work, Sindbis and vaccinia virus recombinants were used to express full-length and carboxyterminally truncated forms of HCV glycoproteins. Our results indicate that the level of secretion can vary depending upon the specific deletion, the viral expression system and the cell type analysed. For E2, a deletion of 85 amino acids (E2 t''" ) was necessary to achieve proper folding of the secreted protein.
Secretion of a truncated form of E1 was also obtained, but this form appears to be misfolded. Interestingly, it was also demonstrated that full-length E2 is required for proper folding of E1.
Previous results have shown that truncated forms of E2 ending at amino acids 661, 664, 668, 683, 699, 710 and 715 are secreted (Lesniewski et al., 1995 ; Matsuura et al., 1994 ; Nishihara et al., 1993 ; Selby et al., 1994) . The size of the deletion did not affect the level of secretion, since truncated E2 glycoproteins ending at amino acids 661, 699, 710 and 715 were equally secreted (Selby et al., 1994) , and we obtained similar results for truncated E2 glycoproteins expressed by vaccinia virus. However, using the Sindbis virus expression system, a truncation to residue 661 was necessary for efficient secretion of E2, indicating that the vector can influence the level of secretion. These results suggest that the Sindbis virus expression system might inhibit secretion of some proteins or, alternatively, that the vaccinia virus\T7 system facilitates secretion of proteins which are misfolded and would not CDAE otherwise be secreted. Among secreted forms of truncated E2 glycoproteins, only E2 t''" expressed by vaccinia or Sindbis virus appeared to be properly folded. As a general rule, newly synthesized proteins that have acquired a properly folded structure are transported from the ER to their final destinations, whereas incompletely folded or misfolded proteins are retained and eventually degraded (Hammond & Helenius, 1995) . This conformation-based sorting phenomenon has been called ' quality control' (Hurtley & Helenius, 1989) . It seems therefore that some truncated forms expressed by vaccinia virus have escaped quality control, suggesting that the vaccinia virus vector could interfere at this level.
Escape from quality control might be due to the deletion of a sequence important for recognition by one of the ER chaperones. The criteria by which folded and unfolded proteins are distinguished from each other are still poorly understood. It seems that the system of retention is partly based on general properties of incompletely folded molecules, including the presence of hydrophobic peptide elements exposed on the surface, free exposed sulfhydryl groups or partially glucosetrimmed oligosaccharides and the tendency to form large aggregates (Hammond & Helenius, 1995) . In the case of E1 t$"" , we might expect that, due to a large carboxy-terminal deletion, this protein has acquired non-native states of folding which are loosely recognized by the molecules involved in quality control. Secretion of a truncated form of E1 has been reported previously (Matsuura et al., 1994) , but this truncated E1 ending at amino acid 340 also had an internal deletion between amino acids 262 and 290. Since our E1 t$"" , which contains this internal sequence, is secreted, it is unlikely that the hydrophobic sequence between amino acids 262 and 290 plays a role in anchoring E1 in membranes. It is more likely that, as for E1 t$"" , truncated E1 with an internal deletion was secreted due to the deletion of a hydrophobic region potentially recognized by the molecules involved in quality control. Such an escape from quality control has been described for deleted forms of immunoglobulin heavy chains (Hendershot et al., 1987) . Deletion of the constant region (CH1) domain, but not others, leads to loss of binding by the molecular chaperone BiP and to secretion of the unassembled and otherwise transport-incompetent heavy chains (Hendershot et al., 1987) .
Folding of E1 is dependent on the expression of E2. We have previously shown that E2-NS2 (a precursor of E2) and E1 can interact very early after their cleavage from the polyprotein (Dubuisson et al., 1994) . Although folding of these proteins is not complete at this stage (Deleersnyder et al., 1997 ; Dubuisson & Rice, 1996) , rapid interaction of E2-NS2 (or E2) and E1 may protect E1 from interacting with itself or other proteins which could lead to the formation of irreversible aggregates. It should be noted that even in the presence of E2, aggregates are formed and the level of proper folding and assembly is low (Deleersnyder et al., 1997 ; Dubuisson et al., 1994) . This ' chaperone-like ' activity of E2 is similar to the role of prM of Japanese encephalitis virus (Konishi & Mason, 1993) .
Cosynthesis of prM is indeed required for proper folding, membrane association and assembly of the E protein.
Truncated forms of E1 and E2 are released as complexes when they are coexpressed. Similar results have been previously observed for other truncated forms of E1 and E2 (Matsuura et al., 1994) . However, our data suggest that these complexes are not properly folded. In addition, our results confirm the observation that the carboxy-terminal domain of E2 (presumably its transmembrane domain) is important for E1E2 heterodimer formation, as previously suggested by Selby et al. (1994) . One of the roles of the carboxy-terminal domain of E2 is probably indirect, anchoring the ectodomain of E2 in close proximity to E1 to assist in its folding. In addition, the transmembrane domains of HCV glycoproteins could also interact directly to stabilize E1E2 heterodimers. Alternatively, regions in both transmembrane domains and ectodomains of HCV glycoproteins could be important in stabilizing E1E2 heterodimers, and disruption in one domain (e.g. transmembrane domain) could impede the formation of properly folded heterodimers.
Thus far, E2 t''" is the best candidate for a soluble form which is likely to mimic some properties of the E2 present in HCV particles. Further biochemical and structural characterization of this truncated form will hopefully yield new insights into its function in the virus life cycle. In addition, this form of E2 may also be useful in developing new serodiagnostic assays and subunit vaccines.
